As of 2025-11-14, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -7.15 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 20.42 USD, the upside of Edgewise Therapeutics Inc is -135.03%.
Based on its market price of 20.42 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 135.03%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.15 - -7.15 | -7.15 | -135.03% |
| P/E | (29.01) - (31.33) | (29.83) | -246.1% |
| DDM - Stable | (15.39) - (64.84) | (40.12) | -296.5% |
| DDM - Multi | (0.22) - (0.70) | (0.34) | -101.6% |
| Market Cap (mil) | 2,151.25 |
| Beta | 2.05 |
| Outstanding shares (mil) | 105.35 |
| Enterprise Value (mil) | 2,107.84 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.25% |
| Cost of Debt | 5.00% |
| WACC | 6.07% |